148 related articles for article (PubMed ID: 7931189)
41. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis B virus DNA in liver tissue of chronic HBsAg carriers in childhood and its relationship to other viral markers.
Wirth S; Keller KM; Schaefer E; Zabel B
J Pediatr Gastroenterol Nutr; 1992 May; 14(4):431-5. PubMed ID: 1517947
[TBL] [Abstract][Full Text] [Related]
43. Quantitative detection of hepatitis B virus DNA in sera from patients with acute hepatitis B.
Tassopoulos NC; Kuhns MC; Koutelou MG; McNamara AL; Todoulos A
Dig Dis Sci; 1993 Dec; 38(12):2156-62. PubMed ID: 8261815
[TBL] [Abstract][Full Text] [Related]
44. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis B virus DNA in asymptomatic HBsAg carriers: comparison with HBeAg/anti-HBe status.
Berris B; Sampliner RE; Sooknanan R; Feinman SV
J Med Virol; 1987 Nov; 23(3):233-9. PubMed ID: 3430143
[TBL] [Abstract][Full Text] [Related]
46. [The determination of serum hepatitis B virus DNA by polymerase chain reaction in hepatitis B patients treated with alpha-interferon].
Xu JY; Brown D; Dusheikot G
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):278-80, 316-7. PubMed ID: 1478124
[TBL] [Abstract][Full Text] [Related]
47. Natural history of hepatitis B virus infection in renal transplant recipients--a fifteen-year follow-up.
Dusheiko G; Song E; Bowyer S; Whitcutt M; Maier G; Meyers A; Kew MC
Hepatology; 1983; 3(3):330-6. PubMed ID: 6341196
[TBL] [Abstract][Full Text] [Related]
48. Effects of interferon-alpha therapy on serum and liver HBV DNA in patients with chronic hepatitis B.
Feinman SV; Berris B; Sooknanan R; Fernandes B; Bojarski S
Dig Dis Sci; 1992 Oct; 37(10):1477-82. PubMed ID: 1395992
[TBL] [Abstract][Full Text] [Related]
49. Detection of hepatitis B virus DNA in spermatozoa, urine, saliva and leucocytes, of chronic HBsAg carriers. A lack of relationship with serum markers of replication.
Davison F; Alexander GJ; Trowbridge R; Fagan EA; Williams R
J Hepatol; 1987 Feb; 4(1):37-44. PubMed ID: 3571932
[TBL] [Abstract][Full Text] [Related]
50. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
[TBL] [Abstract][Full Text] [Related]
51. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.
Günther S; Meisel H; Reip A; Miska S; Krüger DH; Will H
Virology; 1992 Mar; 187(1):271-9. PubMed ID: 1736529
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis B virus DNA in patients with HBsAg in south western Nigeria.
Odaibo GN; Ola SO; Olaleye OD
J Med Virol; 2013 Feb; 85(2):214-8. PubMed ID: 23161583
[TBL] [Abstract][Full Text] [Related]
53. Detection of polyadenylated RNA in hepatitis B virus-infected peripheral blood mononuclear cells by polymerase chain reaction.
Baginski I; Chemin I; Bouffard P; Hantz O; Trepo C
J Infect Dis; 1991 May; 163(5):996-1000. PubMed ID: 1708401
[TBL] [Abstract][Full Text] [Related]
54. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
55. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
[TBL] [Abstract][Full Text] [Related]
56. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases.
Cabrerizo M; Bartolomé J; Caramelo C; Barril G; Carreno V
Hepatology; 2000 Jul; 32(1):116-23. PubMed ID: 10869298
[TBL] [Abstract][Full Text] [Related]
57. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
58. [The presence of nucleotide sequences of the hepatitis B virus in peripheral lymphocytes of patients with acute hepatitis B].
Lai ME; Farci P; Figus A; Mulargia AP; Orgiana G; Cuboni C; Angioni G; Balestrieri A
Minerva Med; 1989 Apr; 80(4):335-9. PubMed ID: 2725933
[TBL] [Abstract][Full Text] [Related]
59. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
60. Precore and core mutations in HBV from individuals in India with chronic infection.
Valliammai T; Thyagarajan SP; Zuckerman AJ; Harrison TJ
J Med Virol; 1995 Mar; 45(3):321-5. PubMed ID: 7775955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
